Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
276 studies found for:    Open Studies | "Epilepsy"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Epilepsy"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Supporting Treatment Adherence Regimens in Pediatric Epilepsy: The STAR Trial
Condition: Epilepsy
Interventions: Behavioral: STAR;   Behavioral: Education Only
2 Recruiting The Human Epilepsy Project
Condition: Focal Epilepsy
Intervention:
3 Available Treatment of Drug Resistant Epilepsy
Condition: Epilepsy
Interventions: Drug: cannabidiol;   Other: Blood Test
4 Not yet recruiting A Global, Postmarketing Observational Safety Study to Evaluate the Safety and Tolerability of Fycompa (Perampanel) as Add-on Therapy in Epilepsy Patients Aged Greater Than or Equal to 12 Years
Condition: Epilepsy
Intervention: Drug: Perampanel
5 Recruiting Epilepsy Birth Control Registry
Condition: Epilepsy
Intervention: Other: Non-interventional
6 Recruiting Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
Condition: Epilepsy
Intervention: Drug: perampanel
7 Not yet recruiting An Exploratory RCT of a Psychosocial Group Intervention for Epilepsy
Condition: Epilepsy
Interventions: Behavioral: Psychosocial Intervention Group;   Other: Waiting list control
8 Not yet recruiting Subcutaneous EEG in Epilepsy
Condition: Temporal Lobe Epilepsy
Intervention: Device: Hypo-safe implantable EEG electrode and data storage device
9 Recruiting Transcutaneous Auricular Vagus Nerve Stimulation for Pediatric Epilepsy
Condition: Epilepsy
Intervention: Device: ear vagus nerve stimulator
10 Recruiting Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Condition: Epilepsy
Intervention: Drug: perampanel
11 Recruiting Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy
Condition: Epilepsy
Intervention: Drug: Clobazam
12 Recruiting Ketogenic Diet Program for Epilepsy
Condition: Epilepsy
Intervention: Other: Ketogenic Diet
13 Not yet recruiting COMETE Study : COgnitive Rehabilitation of MEmory in Temporal Epilepsy
Condition: Epilepsy
Intervention: Other: COMETE
14 Recruiting Multimodal Functional Neuroimaging in Epilepsy Patients
Condition: Epilepsy
Intervention:
15 Recruiting High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy
Condition: Epilepsy
Intervention: Device: HD Transcranial Direct Stimulation
16 Recruiting Fecal Microbiota Transplantation for Epilepsy
Condition: Epilepsy
Interventions: Drug: Fecal Microbiota suspension;   Drug: Normal saline
17 Not yet recruiting Characterization of Epilepsy Patients BEEP 2b
Condition: Epilepsy
Interventions: Drug: Oxcarbmazepine (brand name vs generic drugs);   Drug: Divalproex Sodium (brand name vs generic drugs);   Drug: Carbamazepine (brand name vs generic drugs);   Drug: Lamotrigine (brand name vs generic drugs);   Drug: levetiracetam (brand name vs generic drugs);   Drug: Topiramate (brand name vs generic drugs);   Drug: Zonisamide (brand name vs generic drugs);   Drug: Phenytoin sodium (brand name vs generic drugs)
18 Recruiting Clinical Trial of Vagus Nerve Stimulation for Treatment of Refractory Epilepsy
Condition: Refractory Epilepsy
Intervention: Device: Vagus Nerve Stimulation
19 Not yet recruiting Big Data Construction and Biological Etiological Epidemiology Study of Children Epilepsy in China
Condition: Epilepsy
Intervention:
20 Recruiting Phenomenological Approach of Epilepsy in Patients With Epilepsy
Condition: Epilepsy
Intervention: Other: interview with a psychologist

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.